Adoptive immunotherapy of brain tumor with activated lymphoid cells. By utilizing interleukin 2-dependent tumor-specific cytotoxic T lymphocyte cell line.
1) MillisGB, CarlsonG, PaetkauV: Generation of cytotoxic lymphocytes to syngeneic tumors by using co-stimulator (interleukin 2 ); in vivo activity. J. Immunol., 125: 1904-1909, 1980
2) CheeverMA, GreenbergPD, FeferA: Specific adoptive therapy pf established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and non-specifically expanded by culture with interleukin 2. J. Immunol., 126 1318-1322, 1981
3) CheeverMA, GreenbergPD, FeferA, GillisS: Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2. J. Exp. Med., 155: 968-980, 1982
4) EberleinTJ, RosensteinM, SpiessP, WesleyR, RosenbergSA: Adoptive chemoimmunotherapy of a syngeneic murine lymphoma with long-term lymphoid cell lines expanded in T cell growthfactor. Cancer Immunol. Immunother., 13: 5-13, 1982
5) EberleinTJ, RosensteinM, RosenbergSA: Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2. J. Exp. Med., 156: 385-397, 1982